Edgestream Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.69M Buy
+24,853
New +$10.5M 0.29% 68
2026
Q1
Sell
-13,505
Closed -$6.3M 964
2025
Q4
$6.3M Buy
13,505
+12,524
+1,277% +$5.81M 0.18% 178
2025
Q3
$418K Buy
+981
New +$380K 0.01% 755
2024
Q4
Sell
-20,133
Closed -$8.18M 948
2024
Q3
$8.18M Buy
+20,133
New +$7.37M 0.36% 22
2024
Q1
Sell
-1,446
Closed -$391K 893
2023
Q4
$391K Buy
+1,446
New +$357K 0.03% 662
2023
Q3
Sell
-7,119
Closed -$2.16M 872
2023
Q2
$2.16M Buy
+7,119
New +$1.98M 0.2% 164

Other funds holding HCA

Edgestream Partners's HCA Position: Q2 2026 in Review

Edgestream Partners opened a new position in HCA Healthcare (HCA) in Q2 2026: 24,853 shares worth $9.69M. The stake represents 0.29% of the portfolio and ranks #68 among its holdings. This is a return to the name: Edgestream Partners previously reported a position in HCA as recently as Q4 2025.

Edgestream Partners first reported a position in HCA in Q2 2023 and has held it in 6 quarters since. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Edgestream Partners held 24,853 shares of HCA Healthcare worth $9.69M as of Q2 2026.
  • HCA Healthcare was a new Edgestream Partners position in Q2 2026.
  • HCA Healthcare made up 0.29% of Edgestream Partners's portfolio in Q2 2026, its #68 holding.
  • Edgestream Partners first reported a position in HCA Healthcare in Q2 2023 and has held it in 6 quarters since.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.